Bethesda, Maryland 20892

  • Unspecified Adult Solid Tumor, Protocol Specific


RATIONALE: Collecting and storing samples of tumor tissue, blood, urine, and cerebrospinal fluid from patients to test in the laboratory may help the study of cancer. PURPOSE: This study is collecting and storing tissue and fluid samples from patients receiving standard care at the National Cancer Institute.

Study summary:

OBJECTIVES: - Collect and store biological samples from patients at the National Cancer Institute not currently enrolled in an active research study while providing standard care treatment and medical follow up. OUTLINE: Biological samples, including tumor tissue, surgical tissue, blood, urine, and cerebrospinal fluid are collected during usual care and stored. PROJECTED ACCRUAL: A total of 1,000 patients will be accrued for this study.


DISEASE CHARACTERISTICS: - Meets 1 of the following criteria: - Enrolled in a Center for Cancer Research (CCR) nontreatment research study and requires standard of care therapy - Eligible for a CCR research study in the near future but requires cancer therapy prior to enrollment - Standard of care therapy is requested through the Medical Oncology Clinical Research Unit (MOCRU) consult service - Treatment of cancer or risk of cancer would add significant value to the Medical Oncology fellowship training program - Previously enrolled in National Cancer Institute (NCI) trials in which important scientific endpoints, including natural history of the disease and late toxicities, were collected - Medical welfare could be seriously compromised by referral back to the community, such as rare or complex disease where community treatment is inadequate or adequate community resources are unavailable - Received majority of prior specialized medical care on research protocols at CCR and approaching the end of the natural history of disease - Diagnosed with cancer or HIV, or at risk for cancer or HIV, and cancer treatment or management at the NCI is requested via the MOCRU - CCR investigator decides it is in the best interest of the patient and NCI for patient to be enrolled on protocol and continue to receive care and follow up within the MOCRU PATIENT CHARACTERISTICS: - Not specified PRIOR CONCURRENT THERAPY: - Not specified



Primary Contact:

Principal Investigator
Giuseppe Giaccone, MD, PhD
NCI - Medical Oncology Branch

Backup Contact:


Location Contact:

Bethesda, Maryland 20892
United States

Clinical Trials Office - Warren Grant Magnusen Clinical Center
Phone: 888-NCI-1937

Site Status: Recruiting

Data Source:

Date Processed: December 07, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.